| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission
|
Vydra, Jan
|
|
2018
|
18 |
2 |
p. 106-113
|
artikel
|
| 2 |
Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER–Medicare Cohort
|
Koff, Jean L.
|
|
2018
|
18 |
2 |
p. e115-e121
|
artikel
|
| 3 |
Chemotherapy-induced Nausea and Vomiting Prophylaxis in High-dose Melphalan and Autologous Stem Cell Transplantation
|
Tendas, Andrea
|
|
2018
|
18 |
2 |
p. 161-162
|
artikel
|
| 4 |
Considerations for Successful Treatment-free Remission in Chronic Myeloid Leukemia
|
Goldberg, Stuart L.
|
|
2018
|
18 |
2 |
p. 98-105
|
artikel
|
| 5 |
Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging
|
Song, Erin J.
|
|
2018
|
18 |
2 |
p. 145-151
|
artikel
|
| 6 |
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
|
Fluge, Øystein
|
|
2018
|
18 |
2 |
p. 125-135.e3
|
artikel
|
| 7 |
Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom
|
Sinha, Richa
|
|
2018
|
18 |
2 |
p. e131-e142
|
artikel
|
| 8 |
Danazol as First-Line Therapy for Myelodysplastic Syndrome
|
Colunga-Pedraza, Perla Rocío
|
|
2018
|
18 |
2 |
p. e109-e113
|
artikel
|
| 9 |
Editorial Board
|
|
|
2018
|
18 |
2 |
p. A5
|
artikel
|
| 10 |
HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab
|
Chang, Elaine
|
|
2018
|
18 |
2 |
p. e143-e146
|
artikel
|
| 11 |
Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review
|
Shallis, Rory M.
|
|
2018
|
18 |
2 |
p. e123-e129
|
artikel
|
| 12 |
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry
|
Mato, Anthony
|
|
2018
|
18 |
2 |
p. 114-124.e2
|
artikel
|
| 13 |
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States
|
Hari, Parameswaran
|
|
2018
|
18 |
2 |
p. 152-160
|
artikel
|
| 14 |
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
|
Riedell, Peter A.
|
|
2018
|
18 |
2 |
p. 91-97
|
artikel
|
| 15 |
SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma
|
Watkins, Marcus P.
|
|
2018
|
18 |
2 |
p. 81-90
|
artikel
|
| 16 |
Table of Contents
|
|
|
2018
|
18 |
2 |
p. A7-A9
|
artikel
|
| 17 |
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study
|
Santini, Valeria
|
|
2018
|
18 |
2 |
p. 136-144.e7
|
artikel
|
Tijdschrift beschrijving